Crossmark

Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors

Crossref DOI link: https://doi.org/10.1186/s12885-018-4579-z

Published Online: 2018-07-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barazeghi, Elham

Prabhawa, Surendra

Norlén, Olov

Hellman, Per

Stålberg, Peter

Westin, Gunnar https://orcid.org/0000-0003-3901-8497
License Information

Text and Data Mining valid from 2018-07-25
More Information

Article History

Received: 29 September 2017

Accepted: 7 June 2018

First Online: 25 July 2018

Ethics approval and consent to participate

: Written informed consent has been achieved from all the patients for the use of tissue and study of the disease, and ethical approval from the Regional Ethical Review Board in Uppsala was obtained (EPN 2011/375). Our Institutional Review Board-approval includes both the production of new cell lines from consenting patients and the use of commercial and/or already published cell lines. All methods were performed in accordance with relevant guidelines and regulations.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.